Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Nitric-oxide supplementation for treatment of long-term complications in argininosuccinic aciduria.

Sandesh C S Nagamani | Philippe M Campeau | Oleg A Shchelochkov | Muralidhar H Premkumar | Kilian Guse | Nicola Brunetti-Pierri | Yuqing Chen | Qin Sun | Yaoping Tang | Donna Palmer | Anilkumar K Reddy | Li Li | Timothy C Slesnick | Daniel I Feig | Susan Caudle | David Harrison | Leonardo Salviati | Juan C Marini | Nathan S Bryan | Ayelet Erez | Brendan Lee
American journal of human genetics | 2012

Argininosuccinate lyase (ASL) is required for the synthesis and channeling of L-arginine to nitric oxide synthase (NOS) for nitric oxide (NO) production. Congenital ASL deficiency causes argininosuccinic aciduria (ASA), the second most common urea-cycle disorder, and leads to deficiency of both ureagenesis and NO production. Subjects with ASA have been reported to develop long-term complications such as hypertension and neurocognitive deficits despite early initiation of therapy and the absence of documented hyperammonemia. In order to distinguish the relative contributions of the hepatic urea-cycle defect from those of the NO deficiency to the phenotype, we performed liver-directed gene therapy in a mouse model of ASA. Whereas the gene therapy corrected the ureagenesis defect, the systemic hypertension in mice could be corrected by treatment with an exogenous NO source. In an ASA subject with severe hypertension refractory to antihypertensive medications, monotherapy with NO supplements resulted in the long-term control of hypertension and a decrease in cardiac hypertrophy. In addition, the NO therapy was associated with an improvement in some neuropsychological parameters pertaining to verbal memory and nonverbal problem solving. Our data show that ASA, in addition to being a classical urea-cycle disorder, is also a model of congenital human NO deficiency and that ASA subjects could potentially benefit from NO supplementation. Hence, NO supplementation should be investigated for the long-term treatment of this condition.

Pubmed ID: 22541557

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCRR NIH HHS, United States
    Id: K01 RR000188
  • Agency: NIBIB NIH HHS, United States
    Id: P41 EB002182
  • Agency: NIGMS NIH HHS, United States
    Id: TR01 GM90310
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM090310
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007526
  • Agency: CIHR, Canada
  • Agency: NCRR NIH HHS, United States
    Id: RR00188
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL022512
  • Agency: NIGMS NIH HHS, United States
    Id: GM07526
  • Agency: NCRR NIH HHS, United States
    Id: RR19453
  • Agency: NCRR NIH HHS, United States
    Id: RR024173
  • Agency: NIDDK NIH HHS, United States
    Id: K08 DK081735
  • Agency: NCRR NIH HHS, United States
    Id: P41 RR011795
  • Agency: NIGMS NIH HHS, United States
    Id: GM90310
  • Agency: NICHD NIH HHS, United States
    Id: HD024064
  • Agency: NCRR NIH HHS, United States
    Id: M01 RR000188
  • Agency: NICHD NIH HHS, United States
    Id: U54 HD061221
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK054450
  • Agency: NHLBI NIH HHS, United States
    Id: HL22512
  • Agency: NIDDK NIH HHS, United States
    Id: DK081735
  • Agency: NHLBI NIH HHS, United States
    Id: K25 HL073041
  • Agency: NICHD NIH HHS, United States
    Id: P30 HD024064
  • Agency: NCRR NIH HHS, United States
    Id: UL1 RR024148
  • Agency: NCRR NIH HHS, United States
    Id: U54 RR019453
  • Agency: NHLBI NIH HHS, United States
    Id: HL73041
  • Agency: NHLBI NIH HHS, United States
    Id: R37 HL022512
  • Agency: NIDDK NIH HHS, United States
    Id: DK54450
  • Agency: NCRR NIH HHS, United States
    Id: K01 RR024173

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


OMIM (tool)

RRID:SCR_006437

Online catalog of human genes and genetic disorders, for clinical features, phenotypes and genes. Collection of human genes and genetic phenotypes, focusing on relationship between phenotype and genotype. Referenced overviews in OMIM contain information on all known mendelian disorders and variety of related genes. It is updated daily, and entries contain copious links to other genetics resources.

View all literature mentions